Sector & Industry Research
Wholesale-Drugs, Proprietaries & Druggists' Sundries Stocks
Explore companies assigned to Wholesale-Drugs, Proprietaries & Druggists' Sundries. Open a stock page for detailed price, fundamentals, technical indicators, forecasts and available filings.
COMPANY UNIVERSE
Wholesale-Drugs, Proprietaries & Druggists' Sundries company directory
Sorted by available market capitalization. Missing values remain at the bottom; this is not an investment recommendation.
10stocks foundDatabase classification
Companies in Wholesale-Drugs, Proprietaries & Druggists' Sundries
Click a ticker or company to open its stock research page.
| Ticker | Company | Industry | Exchange | Market cap | Research |
|---|---|---|---|---|---|
| MCK | McKesson Corporation | Wholesale-Drugs, Proprietaries & Druggists' Sundries | XNYS | $115,444,025,000 | Open research → |
| COR | Cencora, Inc. | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES | XNYS | $61,322,309,473 | Open research → |
| CAH | Cardinal Health, Inc. | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES | XNYS | $55,333,421,081 | Open research → |
| HLF | Herbalife Ltd. | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES | XNYS | $1,365,588,041 | Open research → |
| NUS | NuSkin Enterprises, Inc. | Wholesale-Drugs, Proprietaries & Druggists' Sundries | XNYS | $234,260,280 | Open research → |
| ZSTK | ZeroStack Corp. | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES | XNAS | $100,703,175 | Open research → |
| COSM | Cosmos Holdings Inc. | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES | XNAS | $31,639,258 | Open research → |
| ESYN | EnerSyn Global Inc. | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES | XNAS | $16,689,024 | Open research → |
| MEDS | DataMeds AI, Inc. | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES | XNAS | $9,464,994 | Open research → |
| HKPD | Cellyan Biotechnology Co., Ltd | Wholesale-Drugs, Proprietaries & Druggists' Sundries | XNAS | $5,523,555 | Open research → |
Classification reflects stored metadata. Market cap may be stale or unavailable. Not financial advice.